Cellectis S.A.
CLLS
$2.85
-$0.01-0.35%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 25.23% | 7.36% | 63.62% | 1.86% | 18.71% |
Total Depreciation and Amortization | 4.57% | 4.76% | 3.44% | 8.84% | 8.38% |
Total Amortization of Deferred Charges | 998.55% | 998.55% | 998.55% | -85.98% | -85.98% |
Total Other Non-Cash Items | 6,256.82% | 177.74% | -254.06% | 78.10% | -102.67% |
Change in Net Operating Assets | -119.61% | 2.08% | 9.84% | 1,263.57% | 1,036.38% |
Cash from Operations | -164.76% | 247.68% | 192.90% | 195.54% | 168.99% |
Capital Expenditure | -9.80% | -156.03% | -140.73% | -86.36% | -34.45% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 66.17% | -461.08% | -594.22% | -12,366.75% | -29,383.13% |
Cash from Investing | 65.02% | -442.60% | -562.85% | -4,838.10% | -6,770.48% |
Total Debt Issued | -70.07% | -84.87% | -21.81% | -37.26% | 4.86% |
Total Debt Repaid | 2.98% | 2.52% | 0.79% | -1.11% | -10.65% |
Issuance of Common Stock | -99.84% | 78.34% | 16.31% | 416.45% | 416.45% |
Repurchase of Common Stock | 85.24% | 85.24% | 85.24% | 85.24% | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 30.72% | -512.83% | -41.17% | -546.45% | 45.10% |
Cash from Financing | -107.22% | -2.47% | 7.54% | 252.53% | 339.21% |
Foreign Exchange rate Adjustments | -277.01% | -1,963.46% | -411.31% | -13.76% | 108.55% |
Miscellaneous Cash Flow Adjustments | 100.00% | 200.00% | 200.00% | -- | -200.00% |
Net Change in Cash | -238.01% | -87.53% | -84.96% | 402.83% | 243.51% |